Russell Investments Group Ltd. Purchases 33,426 Shares of Perrigo Company plc $PRGO

Russell Investments Group Ltd. lifted its position in shares of Perrigo Company plc (NYSE:PRGO) by 4.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 825,476 shares of the company’s stock after buying an additional 33,426 shares during the quarter. Russell Investments Group Ltd. owned about 0.60% of Perrigo worth $22,057,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Avantax Advisory Services Inc. grew its holdings in Perrigo by 64.3% during the 1st quarter. Avantax Advisory Services Inc. now owns 14,741 shares of the company’s stock worth $413,000 after acquiring an additional 5,769 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Perrigo by 18.7% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 34,534 shares of the company’s stock valued at $968,000 after purchasing an additional 5,451 shares in the last quarter. LPL Financial LLC grew its stake in Perrigo by 32.4% during the first quarter. LPL Financial LLC now owns 49,969 shares of the company’s stock worth $1,401,000 after purchasing an additional 12,231 shares during the period. Mackenzie Financial Corp acquired a new stake in Perrigo during the first quarter worth approximately $230,000. Finally, Bayforest Capital Ltd bought a new stake in Perrigo in the first quarter worth approximately $246,000. Institutional investors and hedge funds own 95.91% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently commented on PRGO. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Perrigo in a research report on Tuesday. Canaccord Genuity Group dropped their target price on shares of Perrigo from $40.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Jefferies Financial Group reduced their price target on shares of Perrigo from $27.00 to $23.00 and set a “hold” rating for the company in a report on Monday, October 27th. Zacks Research downgraded shares of Perrigo from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Finally, Wall Street Zen lowered shares of Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $22.50.

Perrigo Stock Down 0.5%

PRGO opened at $13.35 on Friday. Perrigo Company plc has a fifty-two week low of $12.17 and a fifty-two week high of $30.93. The firm has a market capitalization of $1.84 billion, a P/E ratio of -23.02 and a beta of 0.42. The company’s 50-day moving average is $18.66 and its 200 day moving average is $23.12. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.32 and a quick ratio of 1.24.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.05. Perrigo had a negative net margin of 1.86% and a positive return on equity of 9.09%. The business had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the firm posted $0.81 EPS. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. Research analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Friday, November 28th will be issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 8.7%. The ex-dividend date is Friday, November 28th. Perrigo’s dividend payout ratio (DPR) is -305.26%.

Insider Buying and Selling at Perrigo

In other Perrigo news, Director Geoffrey M. Parker bought 7,500 shares of the stock in a transaction dated Wednesday, November 12th. The shares were bought at an average cost of $14.18 per share, for a total transaction of $106,350.00. Following the purchase, the director directly owned 17,375 shares of the company’s stock, valued at approximately $246,377.50. This trade represents a 75.95% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Abigail Lennox purchased 1,255 shares of Perrigo stock in a transaction that occurred on Monday, September 8th. The shares were bought at an average price of $22.41 per share, with a total value of $28,124.55. Following the transaction, the executive vice president owned 1,255 shares of the company’s stock, valued at $28,124.55. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. 0.70% of the stock is currently owned by insiders.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.